Masimo Corporation was officially acquired by Danaher Corporation, a leading global science and technology innovator, in a massive cash transaction valuing the medical device enterprise at an enterprise value of approximately $9.9 billion. Following the transaction approval and regulatory clearance, Masimo became a wholly-owned subsidiary operating as a standalone entity within Danaher's specialized diagnostics segment alongside other prominent healthcare brands.